Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479681-24-000014
Filing Date
2024-11-07
Accepted
2024-11-07 16:03:43
Documents
95
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nutx-20240930x10q.htm   iXBRL 10-Q 2750207
2 EX-31.1 nutx-20240930xex31d1.htm EX-31.1 12355
3 EX-31.2 nutx-20240930xex31d2.htm EX-31.2 11309
4 EX-32.1 nutx-20240930xex32d1.htm EX-32.1 8488
5 EX-32.2 nutx-20240930xex32d2.htm EX-32.2 8603
  Complete submission text file 0001479681-24-000014.txt   13084527

Data Files

Seq Description Document Type Size
6 EX-101.SCH nutx-20240930.xsd EX-101.SCH 77547
7 EX-101.CAL nutx-20240930_cal.xml EX-101.CAL 57879
8 EX-101.DEF nutx-20240930_def.xml EX-101.DEF 337799
9 EX-101.LAB nutx-20240930_lab.xml EX-101.LAB 639061
10 EX-101.PRE nutx-20240930_pre.xml EX-101.PRE 525391
98 EXTRACTED XBRL INSTANCE DOCUMENT nutx-20240930x10q_htm.xml XML 2875567
Mailing Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081
Business Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081 (713) 660-0557
Nutex Health, Inc. (Filer) CIK: 0001479681 (see all company filings)

EIN.: 113363609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41346 | Film No.: 241435453
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)